In models of a VX2 liver xenograft tumor, the combination of rapamycin with TACE has also been demonstrated to exhibit anti-tumor neovascularization activity and to inhibit the expression levels of iNOS, HIF-1α, VEGF, Bcl-2, and Bax. The gene discussed is BCL2; the disease is neoplasm.